Watch Ticker

Unicycive Therapeutics, Inc. Common Stock

Go to Unicycive Therapeutics, Inc. Common Stock Website

$4.21

0.00 (0.00%)

Live

Previous Close

$4.21

Day Range

$0 - $0

Previous Day Range

$4.08 - $4.26

Market Cap

$53.5 million USD

Day Vol.

Previous Day Vol.

256013

Currency

USD

Primary Exchange

Nasdaq

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Unicycive Therapeutics provided an update on its New Drug Application for oxylanthanum carbonate, a treatment for hyperphosphatemia in chronic kidney disease patients on dialysis. The FDA identified deficiencies at a third-party manufacturing vendor, and a final decision is expected by the PDUFA action date of June 28, 2025.

Related tickers: UNCY.

Read Full Article

N/A - Unicycive Therapeutics to Present at Upcoming Investor Conferences

Unicycive Therapeutics, a clinical-stage biotechnology company, announced that its CEO will present at two upcoming virtual investment conferences in May and June 2025.

Related tickers: UNCY.

Read Full Article

Trending Tickers

Please sign in to view